Millrace Asset Group’s Adaptive Biotechnologies ADPT Stock Holding History

Millrace Asset Group’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.4M	Buy	+272,681	New	+$1.19M	1.42%	33

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Millrace Asset Group's ADPT Position: Q3 2024 in Review

Millrace Asset Group opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2024: 272,681 shares worth $1.4M. The stake represents 1.42% of the portfolio and ranks #33 among its holdings.

187 funds tracked by Wall St. Rank hold ADPT as of Q3 2024.

Millrace Asset Group held 272,681 shares of Adaptive Biotechnologies worth $1.4M as of Q3 2024.
Adaptive Biotechnologies was a new Millrace Asset Group position in Q3 2024.
Adaptive Biotechnologies made up 1.42% of Millrace Asset Group's portfolio in Q3 2024, its #33 holding.
187 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.